External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients.
Nicolas PeilleronArnaud SeigneurinCaroline HeraultCamille VerryMichel BollaJean-Jacques RambeaudJean-Luc DescotesJean-Alexandre LongGaëlle FiardPublished in: World journal of urology (2020)
The Briganti nomogram in our retrospective cohort showed low accuracy for the prediction of lymph node involvement in an intermediate-risk prostate cancer population.